CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice†

Wagner, Martin, Halilbasic, Emina, Marschall, Hanns‐Ulrich, Zollner, Gernot, Fickert, Peter, Langner, Cord, Zatloukal, Kurt, Denk, Helmut +1 more·2005·Hepatology

Cited by (354)

Items 201–300 of 354

  1. Altered expression of MRP2, MRP3 and UGT2B1 in the liver affects the disposition of morphine and its glucuronide conjugate in a rat model of cholestasis
    Yoshitaka Hasegawa, Shuichi Kishimoto, Kazuhiro Takahashi, Nobuo Inotsume, Yoshikazu Takeuchi, Shoji Fukushima · 2009 · Journal of Pharmacy and Pharmacology
  2. Threshold dose of piperonyl butoxide that induces reactive oxygen species-mediated hepatocarcinogenesis in rats
    Masako Muguruma, Masaomi Kawai, Yasuaki Dewa, Jihei Nishimura, Yukie Saegusa, Hironobu Yasuno, Meilan Jin, Sayaka Matsumoto, Masayoshi Takabatake, Katsuhiko Arai et al. · 2008 · Archives of Toxicology
  3. Ontogeny of mRNA abundance of nuclear receptors and nuclear receptor target genes in young cattle
    D.L. Greger, C. Philipona, J. W. Blum · 2005 · Domestic Animal Endocrinology
  4. Genetics in primary sclerosing cholangitis
    Sigrid Næss, Alexey Shiryaev, Johannes R. Hov, André Franke, Tom H. Karlsen · 2012 · Clinics and Research in Hepatology and Gastroenterology
  5. Gut Microbiota and Adipose Tissue Microenvironment Interactions in Obesity
    Congcong Wang, Zihan Yi, Jiao Ye, Zhong Shen, Fei Yang, Shankuan Zhu · 2023 · Metabolites
  6. Bile acids and bile acid activated receptors in the treatment of Covid-19
    Stefano Fiorucci, Ginevra Urbani, Michele Biagioli, Valentina Sepe, Eleonora Distrutti, Angela Zampella · 2023 · Biochemical Pharmacology
  7. Modulation of Hepatic MRP3/ABCC3 by Xenobiotics and Pathophysiological Conditions: Role in Drug Pharmacokinetics
    Carolina Inés Ghanem, José Enrique Manautou · 2018 · Current Medicinal Chemistry
  8. CHARACTERIZATION OF RESISTANCE TO BROMOBENZENE-INDUCED HEPATOTOXICITY BY MICROARRAY
    Kohji Tanaka, Naoki Kiyosawa, Kyoko Watanabe, Sunao Manabe · 2007 · The Journal of Toxicological Sciences
  9. The hypolipidemic effect of MI-883, the combined CAR agonist/ PXR antagonist, in diet-induced hypercholesterolemia model
    Jan Dusek, Ivana Mejdrová, Klára Dohnalová, Tomáš Smutný, Karel Chalupský, Mária Krutáková, Josef Škoda, Azam Rashidian, Ivona Pávková, Kryštof Škach et al. · 2025 · Nature Communications
  10. Impacts of prenatal environmental exposures on fetal-placental-maternal bile acid homeostasis and long-term health in offspring
    Wen Ming Huang, Wen Hu, Man Fang, Zhang Qi, Yuanzhen Zhang, Hui Wang · 2024 · Ecotoxicology and Environmental Safety
  11. Statins increase cytochrome P450 4F3-mediated eicosanoids production in human liver cells: A PXR dependent mechanism
    Emmanuelle Plée‐Gautier, Joseph Antoun, Sophie Goulitquer, Catherine Le Jossic-Corcos, Brigitte Simon, Yolande Amet, Jean‐Pierre Salaün, Laurent Corcos · 2012 · Biochemical Pharmacology
  12. Functional expression and regulation of drug transporters in monolayer- and sandwich-cultured mouse hepatocytes
    Gordon L. Noel, Marc Le Vée, A Moreau, Bruno Stieger, Yannick Parmentier, Olivier Fardel · 2013 · European Journal of Pharmaceutical Sciences
  13. Impact of chronic unpredicted mild stress-induced depression on repaglinide fate via glucocorticoid signaling pathway
    Hongyan Wei, Ting Zhou, Boyu Tan, Lei Zhang, Mingming Li, Zhijun Xiao, Feng Xu · 2017 · Oncotarget
  14. Constitutive androstane receptor activation promotes bilirubin clearance in a murine model of alcoholic liver disease
    Xiuyan Wang, Liyu Zheng, Jinming Wu, Binbin Tang, Mengqin Zhang, Debin Zhu, Xian-Fan Lin · 2017 · Molecular Medicine Reports
  15. Marine Ligands of the Pregnane X Receptor (PXR): An Overview
    Alejandro Carazo, Přemysl Mladěnka, Petr Pávek · 2019 · Marine Drugs
  16. Exercising the nuclear option to treat cholestasis
    Saul J. Karpen · 2005 · Hepatology
  17. Bile acids attenuate hepatic inflammation during ischemia/reperfusion injury
    Kunpeng Huang, Changyan Wang, Bosheng Mei, Jinglei Li, Tianxing Ren, Hanjing Zhan, Yunwei Zhang, Bowen Zhang, Xinyu Lv, Qi Zhang et al. · 2024 · JHEP Reports
  18. Monitoring Cyp2b10 mRNA expression at cessation of 2-year carcinogenesis bioassay in mouse liver provides evidence for a carcinogenic mechanism devoid of human relevance: The dalcetrapib experience
    J.C. Hoflack, Lutz Arne Mueller, Stephen M. Fowler, Annamaria Braendli-Baiocco, Nicholas A. Flint, Olaf Kuhlmann, T. Singer, A. Roth · 2012 · Toxicology and Applied Pharmacology
  19. Helicobacter hepaticus Infection Promotes Hepatitis and Preneoplastic Foci in Farnesoid X Receptor (FXR) Deficient Mice
    Alton G. Swennes, Alexander Sheh, Nicola M. Parry, Sureshkumar Muthupalani, Kvin Lertpiriyapong, Alexis García, James G. Fox · 2014 · PLoS ONE
  20. Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2−/− mouse model of sclerosing cholangitis via immunomodulatory effects
    Claudia Daniela Fuchs, Emmanuel Dauda Dixon, Tim Hendrikx, Veronika Mlitz, Annika M. Wahlstrom, Marcus Ståhlman, Hubert Scharnagl, Tatjana Stojaković, Christoph J. Binder, Hanns–Ulrich Marschall et al. · 2022 · Hepatology Communications
  21. The Decrease in Farnesoid X Receptor, Pregnane X Receptor and Constitutive Androstane Receptor in the Liver after Intestinal Ischemia-Reperfusion
    Jiro Ogura, Yusuke Terada, Takashi Tsujimoto, Takahiro Koizumi, Kaori Kuwayama, Hajime Maruyama, Asuka Fujikawa, Atsushi Takaya, Masaki Kobayashi, Shirou Itagaki et al. · 2012 · Journal of Pharmacy & Pharmaceutical Sciences
  22. Xenobiotic Nuclear Receptor Signaling Determines Molecular Pathogenesis of Progressive Familial Intrahepatic Cholestasis
    Kang Ho Kim, Jong Min Choi, Feng Li, Armando Arizpe, Clavia Ruth Wooton‐Kee, Sayeepriyadarshini Anakk, Sung Yun Jung, Milton J. Finegold, David D. Moore · 2018 · Endocrinology
  23. Transactivation Potencies of Baikal Seal Constitutive Active/Androstane Receptor by Persistent Organic Pollutants and Brominated Flame Retardants
    Hiroki Sakai, Eun‐Young Kim, Evgeny A. Petrov, Shinsuke Tanabe, Hisato Iwata · 2009 · Environmental Science & Technology
  24. Constitutive expression and phenobarbital modulation of drug metabolizing enzymes and related nuclear receptors in cattle liver and extra-hepatic tissues
    Vanessa Zancanella, Mery Giantin, Rosa Maria Lopparelli, Carlo Nebbia, Mauro Dacasto · 2012 · Xenobiotica
  25. Effects of dexamethasone on mRNA abundance of nuclear receptors and hepatic nuclear receptor target genes in neonatal calves
    D.L. Greger, J. W. Blum · 2006 · Journal of Animal Physiology and Animal Nutrition
  26. Transcriptomic analysis across liver diseases reveals disease-modulating activation of constitutive androstane receptor in cholestasis
    Mathur, Bhoomika, Arif, Waqar, Patton, Megan E., Faiyaz, Rahiman, Liu, Jian, Yeh, Jennifer, Harpavat, Sanjiv, Schoonjans, Kristina, Kalsotra, Auinash, Wheatley, Antony M. et al. · 2020 · JHEP Reports
  27. Review article: nuclear receptors and liver disease – current understanding and new therapeutic implications
    Diaa Elfaki, Einar Stefan Bjornsson, Keith D. Lindor · 2009 · Alimentary Pharmacology & Therapeutics
  28. Effects of human and porcine bile on the proteome of Helicobacter hepaticus
    Arinze Stanley Okoli, Mark J. Raftery, George Louis Mendz · 2012 · Proteome Science
  29. Ginsenoside Rg1 alleviates ANIT-induced intrahepatic cholestasis in rats via activating farnesoid X receptor and regulating transporters and metabolic enzymes
    Qing Xiao, Shujun Zhang, Huina Ren, Ruoyang Du, Jiajun Li, Jinqiu Zhao, Yue Gao, Yali Zhu, Wenxiang Huang · 2020 · Chemico-Biological Interactions
  30. Importance of detoxifying enzymes in differentiating fibrotic development between SHRSP5/Dmcr and SHRSP rats
    Hisao Naito, Xiaofang Jia, Husna Yetti, Yukie Yanagiba, Hazuki Tamada, Kazuya Kitamori, Yumi Hayashi, Dong Wang, Masashi Kato, Akira Ishii et al. · 2016 · Environmental Health and Preventive Medicine
  31. Diurnal expression of ABC and SLC transporters in jejunum is modulated by adrenalectomy
    Karla Vagnerová, Peter Ergang, Matúš Soták, Kateřina Balounová, Pavlína Kvapilová, Martin Vodička, Jiřı́ Pácha · 2019 · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology
  32. Contaminant biomonitoring augmented with a qPCR array indicates hepatic mRNA gene expression effects in wild-collected seabird embryos
    Mason D. King, Geoffrey Y. Su, Doug Crump, Amani Farhat, Vicki Lee Marlatt, Sandi L. Lee, Tony D. Williams, John E. Elliott · 2023 · The Science of The Total Environment
  33. Xenosensors CAR and PXR at Work: Impact on Statin Metabolism
    Maria Marino, Alessandra di Masi, Viviana Trezza, Valentina Pallottini, Fabio Polticelli, Paolo Ascenzi · 2011 · Current Drug Metabolism
  34. Induction of the UDP-Glucuronosyltransferase 1A1 during the Perinatal Period Can Cause Neurodevelopmental Toxicity
    Rika Hirashima, Hirofumi Michimae, Hiroaki Takemoto, Aya Sasaki, Yoshinori Kobayashi, Tomoo Itoh, Robert H. Tukey, Ryoichi Fujiwara · 2016 · Molecular Pharmacology
  35. PF-PLC micelles ameliorate cholestatic liver injury via regulating TLR4/MyD88/NF-κB and PXR/CAR/UGT1A1 signaling pathways in EE-induced rats
    Tengteng Yuan, Shujie Lv, Wei Zhang, Yanan Tang, Hong Chang, Zihan Hu, Liang Fang, Jiaojiao Du, Sifan Wu, Xinli Yang et al. · 2022 · International Journal of Pharmaceutics
  36. Inflammation et métabolisme des médicaments
    Jean‐Marc Pascussi, Marie‐José Vilarem · 2008 · médecine/sciences
  37. Proteomic analysis for the impact of hypercholesterolemia on expressions of hepatic drug transporters and metabolizing enzymes
    Yan Liu, Qiang-Hong Pu, Mingjun Wu, Chao Yu · 2016 · Xenobiotica
  38. Sustained activation of detoxification pathways promotes liver carcinogenesis in response to chronic bile acid-mediated damage
    Collino, Agnese, Termanini, Alberto, Nicoli, Paola, Diaferia, Giuseppe, Polletti, Sara, Recordati, Camilla, Castiglioni, Vittoria, Caruso, Donatella, Mitro, Nico, Natoli, Gioacchino et al. · 2018 · PLOS Genetics
  39. Zonation of multidrug resistance‐associated protein 2 in rat liver after induction with dexamethasone
    Stanislav Mičuda, Leoš Fuksa, Eva Doleželová, Jan Österreicher, Jolana Cermanová, Norbert Cibicek, Jaroslav Mokrý, František Štaud, Jiřina Martı́nková · 2007 · Journal of Gastroenterology and Hepatology
  40. Impairment of Bilirubin Clearance and Intestinal Interleukin-6 Expression in Bile Duct-Ligated Vitamin D Receptor Null Mice
    Michiyasu Ishizawa, Michitaka Ogura, Shigeaki Kato, Makoto Makishima · 2012 · PLoS ONE
  41. Activation of pregnane X receptor protects against cholestatic liver injury by inhibiting hepatocyte pyroptosis
    Hangfei Liang, Xiao Jun Yang, Huilin Li, Xuan Li, Jianing Tian, Hai‐Guo Su, Min Huang, Jian-Hong Fang, Huichang Bi · 2024 · Acta Pharmacologica Sinica
  42. Quantifying Forms and Functions of Enterohepatic Bile Acid Pools in Mice
    Koichi Sudo, Amber Delmas Eliason, Shannon M. Soucy, Kaitlyn E. Barrack, Jiabao Liu, Akshaya Balasubramanian, Chengyi Jenny Shu, Michael J. James, Courtney Lynn Hegner, Henry D. Dionne et al. · 2024 · Cellular and Molecular Gastroenterology and Hepatology
  43. Triclosan exposure causes abnormal bile acid metabolism through IL-1β-NF-κB-Fxr signaling pathway
    Jing Liu, Fang Xu, Mingzhu Guo, Yang Song · 2024 · Ecotoxicology and Environmental Safety
  44. Constitutive androstane receptor, liver pathophysiology and chemical contaminants: current evidence and perspectives
    Francesca De Battistis, Aleksandra Buha Djordjević, Luciano Saso, Alberto Mantovani · 2025 · Frontiers in Endocrinology
  45. Regulatory Mechanics of Constitutive Androstane Receptors: Basal and Ligand-Directed Actions
    Bill Pham, Avery Bancroft Arons, Jeremy G. Vincent, Elias J. Fernandez, Tongye Shen · 2019 · Journal of Chemical Information and Modeling
  46. Dimethyl fumarate attenuates cholestatic liver injury by activating the NRF2 and FXR pathways and suppressing NLRP3/GSDMD signaling in mice
    Ziqian Xu, Wan Tang, Qiaoling Xie, Xinyu Cao, Mengni Zhang, Xiaoxun Zhang, Jin Chai · 2023 · Experimental Cell Research
  47. The impact of cholesterol and its metabolites on drug metabolism
    Tadeja Režen · 2011 · Expert Opinion on Drug Metabolism & Toxicology
  48. Epidermal Growth Factor Represses Constitutive Androstane Receptor Expression in Primary Human Hepatocytes and Favors Regulation by Pregnane X Receptor
    Hugues de Boussac, Claire Gondeau, Philippe Briolotti, Cédric Duret, Fridolin Treindl, Michael Römer, Jean‐Michel Fabre, Astrid Herrero, Jeanne Ramos, Patrick Maurel et al. · 2017 · Drug Metabolism and Disposition
  49. Nuclear receptor ligands in therapy of cholestatic liver disease
    Ekkehard Sturm · 2009 · Frontiers in bioscience
  50. Multifaceted Interactions Between Bile Acids, Their Receptors, and MASH: From Molecular Mechanisms to Clinical Therapeutics
    Xuan Tang, Yuanjiao Zhou, Li Xia, Xiulian Lin, Yao Zhu, Menghan Chen, Jiayao Wang, Yamei Li · 2025 · Molecules
  51. Frankincense vinegar-processing improves the absorption of boswellic acids by regulating bile acid metabolism
    Shitao Peng, Zhiqian Song, Chun Wang, Dongrui Liang, Xiaoying Wan, Zhenli Liu, Aiping Lü, Zhangchi Ning · 2022 · Phytomedicine
  52. Hepatobiliary Transporter Expression in Intercellular Adhesion Molecule 1 Knockout and Fas Receptor-Deficient Mice after Common Bile Duct Ligation Is Independent of the Degree of Inflammation and Oxidative Stress
    Martin Wagner, Gernot Zollner, Peter Fickert, Judith Gumhold, Dagmar Silbert, Andrea Fuchsbichler, Jaspreet S. Gujral, Kurt Zatloukal, Helmut Denk, Hartmut Jaeschke et al. · 2007 · Drug Metabolism and Disposition
  53. Menthol reduces the anticoagulant effect of warfarin by inducing cytochrome P450 2C expression
    Motohiro Hoshino, Nobutomo Ikarashi, Makoto Tsukui, 朝子 黒川, Rina Naito, Midori Suzuki, Kohsuke Yokobori, Takumi Ochiai, Makoto Ishii, Yoshiki Kusunoki et al. · 2014 · European Journal of Pharmaceutical Sciences
  54. P-glycoprotein function and expression during obstructive cholestasis in rats
    Stanislav Mičuda, Eva Doleželová, Leoš Fuksa, Jolana Cermanová, Jan Österreicher, Milos Hroch, Jaroslav Mokrý, Jaroslav Pejchal, Jiřina Martı́nková, František Štaud · 2008 · European Journal of Gastroenterology & Hepatology
  55. Swertianlarin, isolated from Swertia mussotii Franch, increases detoxification enzymes and efflux transporters expression in rats.
    Xinchan Feng, Xiaohuang Du, Sheng Chen, Dongmei Yue, Ying Cheng, Liangjun Zhang, Yu Gao, Shaoxue Li, Lei Chen, Zhihong Peng et al. · 2015 · Europe PMC (PubMed Central)
  56. Advances in understanding the regulatory mechanism of organic solute transporter α-β
    Zhen-Ning Lu, Hongwei He, Na Zhang · 2022 · Life Sciences
  57. Tissue distribution and phenobarbital induction of target SLC‐ and ABC ‐ transporters in cattle
    Vanessa Zancanella, Mery Giantin, Rosa Maria Lopparelli, Carlo Nebbia, Mauro Dacasto · 2012 · Journal of Veterinary Pharmacology and Therapeutics
  58. A combination of dietary N-3 fatty acids and a cyclooxygenase-1 inhibitor attenuates nonalcoholic fatty liver disease in mice
    Viswanathan Saraswathi, Curtis Perriotte‐Olson, Murali Ganesan, Cyrus V Desouza, Yazen Alnouti, Michael J. Duryee, Geoffrey M. Thiele, Tara M. Nordgren, Dahn L. Clemens · 2017 · The Journal of Nutritional Biochemistry
  59. Pregnane X receptor as a therapeutic target for cholestatic liver injury
    Huan Lan, Ying Zhang, Minqi Fan, Bingxin Wu, Caiyan Wang · 2023 · Drug Metabolism Reviews
  60. Studies of Coumarin Derivatives for Constitutive Androstane Receptor (CAR) Activation
    Shin‐Hun Juang, Min‐Tsang Hsieh, Pei-Ling Hsu, Ju-Ling Chen, Hui‐Kang Liu, Fong-Pin Liang, Sheng‐Chu Kuo, Chen‐Yuan Chiu, Shing‐Hwa Liu, Chen‐Hsi Chou et al. · 2020 · Molecules
  61. Gut microbiota-derived metabolites as systemic messengers: mechanisms of gut-organ communication and translational opportunities
    Cuijiao Feng, Qiuwen He, Lai‐Yu Kwok, Zhihong Sun · 2026 · Trends in Food Science & Technology
  62. New Approach Methods for Hazard Identification: A Case Study with Azole Fungicides Affecting Molecular Targets Associated with the Adverse Outcome Pathway for Cholestasis
    Constanze Knebel, Roderich D. Süßmuth, Helen Hammer, Albert Braeuning, Philip Marx‐Stoelting · 2022 · Cells
  63. MAPL loss dysregulates bile and liver metabolism in mice
    Vanessa Goyon, Aurèle Besse‐Patin, Rodolfo Zunino, Olesia Ignatenko, Mai Nguyen, Étienne Coyaud, Jonathan M. Lee, Bich Nguyen, Brian Raught, Heidi May McBride · 2023 · EMBO Reports
  64. Combined Rifampicin and Ursodeoxycholic Acid Treatment Does Not Amplify Rifampicin Effects on Hepatic Detoxification and Transport Systems in Humans
    Hanns–Ulrich Marschall, Martin Wagner, Gernot Zollner, Peter Fickert, Dagmar Silbert, Ulf O Gustafsson, Staffan Sahlin, Michael A Trauner · 2012 · Digestion
  65. The Constitutive Androstane Receptor (CAR): A Nuclear Receptor in Health and Disease
    Amit K. Dash, Ashutosh S. Yende, Sudhir Kumar, Shashi Kala Singh, Deepak Kotiya, Manjul Rana, Rakesh K. Tyagi · 2014 · Journal of Endocrinology & Reproduction
  66. Prognostic molecular markers in pediatric liver disease – Are there any?
    Jon Nielsen, Vibeke Brix Christensen, Lise Borgwardt, Allan Rasmussen, Oľga Østrup, Mette Skalshøi Kjær · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  67. Investigation of dichlorodiphenyltrichloroethane (DDT) on xenobiotic enzyme disruption and metabolomic bile acid biosynthesis in DDT-sprayed areas using wild rats
    Kodai MOTOHIRA, Yared Beyene Yohannes, Yoshinori Ikenaka, Akifumi Eguchi, Shouta M.M. Nakayama, Victor Wepener, Nico Jacobus Smit, Johan HJ VAN VUREN, Mayumi Ishizuka · 2023 · Journal of Veterinary Medical Science
  68. Gene‐specific alterations of hepatic gene expression by ligand activation or hepatocyte‐selective inhibition of retinoid X receptor‐α signalling during inflammation
    Astrid Kosters, Feng Tian, Yvonne Yu‐Jie Wan, Saul J. Karpen · 2011 · Liver International
  69. Regulation of Cytochrome P450 2a5 by Artemisia capillaris and 6,7-Dimethylesculetin in Mouse Hepatocytes
    Sangsoo Daniel Kim, Larry Morgan, Elyse Hargreaves, Xiaoying Zhang, Zhihui Jiang, Monica Antenos, Ben Li, Gordon M. Kirby · 2021 · Frontiers in Pharmacology
  70. Effects of simvastatin on nuclear receptors, drug metabolizing enzymes and transporters expression in Human Umbilical Vein Endothelial Cells
    Joanna Łapczuk-Romańska, Anna Wajda, Ewa Pius‐Sadowska, Mateusz Kurzawski, Andrzej Niedzielski, Bogusław Machaliński, Marek Droździk · 2018 · Pharmacological Reports
  71. Activation of cAMP-Dependent Signaling Pathway Induces Mouse Organic Anion Transporting Polypeptide 2 Expression
    Chuan Chen, Xingguo Cheng, Matthew Z. Dieter, Yuji Tanaka, Curtis D. Klaassen · 2007 · Molecular Pharmacology
  72. Sex-specific effects of gut microbiome on shaping bile acid metabolism
    Yifei Yang, Liang Chi, Yun-Chung Hsiao, Kun Lü · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  73. Role of genetics in diagnosis and therapy of acquired liver disease
    Vincent Zimmer, Frank Lammert · 2013 · Molecular Aspects of Medicine
  74. Rifampicin Induces Bicarbonate-Rich Choleresis in Rats: Involvement of Anion Exchanger 2
    Wei Wang, Xiaofei Ren, Yi Cai, Lihong Chen, Weiping Zhang, Jianming Xu · 2015 · Digestive Diseases and Sciences
  75. Statins, Fibrates, and Other Peroxisome Proliferator-Activated Receptor Agonists for the Treatment of Cholestatic Liver Diseases.
    Alanna Dubrovsky, Christopher L. Bowlus · 2020 · PubMed Central
  76. The Bile Acid Derivatives Lithocholic Acid Acetate and Lithocholic Acid Propionate are Functionally Selective Vitamin D Receptor Ligands
    Makoto Makishima, Sachiko Yamada · 2011 · Elsevier eBooks
  77. Xenobiotic Receptors CAR and PXR
    Curtis D. Klaassen, Hong Lü · 2010 · Springer eBooks
  78. Exploring Adverse Event Associations of Predicted PXR Agonists Using the FAERS Database
    Saki Yamada, Yoshihiro Uesawa · 2025 · International Journal of Molecular Sciences
  79. Evaluation of Shiitake Mushroom (Lentinula edodes) Supplementation on the Blood Parameters of Young Thoroughbred Racehorses
    Maria Soroko, Wanda Górniak, Paulina Zielińska, Aleksander Górniak, Nina Čebulj-Kadunc, Mariusz Korczyński · 2022 · Animals
  80. Switch/sucrose non-fermentable complex interacts with constitutive androstane receptor to regulate drug-metabolizing enzymes and transporters in the liver
    Kiamu Kurosawa, Masataka Nakano, Itsuki Yokoseki, Mei Tomii, Yuichiro Higuchi, Shotaro Uehara, Nao Yoneda, Hiroshi Suemizu, Tatsuki Fukami, Miki Nakajima · 2025 · Drug Metabolism and Disposition
  81. Gender-related differences in drug effects: The role of multidrug resistance proteins
    О. V. Smirnova · 2012 · Human Physiology
  82. Pregnane X receptor alleviates sepsis-induced liver injury through activation of yes-associated protein in mice
    Chenghua Wu, Shuang Hu, Dan Li, Xiaowen Jiang, Hui Ouyang, Guofang Bi, Peng Wang, Fengting Liang, Wenhong Zhou, Xiao Jun Yang et al. · 2025 · Acta Pharmacologica Sinica
  83. Activation of pregnane X receptor-organic anion transporting polypeptide 1a/b /P-glycoprotein/multidrug resistance protein 2 axis mediates the accelerated blood and liver clearance of PEGylated liposomes
    Jianquan Pan, Cheng Zhang, Huiyu Lu, Xue Zhang, Huiya Deng, Yunna Chen, Lei Wang, Sheng Zhang, Fengling Wang, Weidong Chen · 2025 · Drug Metabolism and Disposition
  84. Drug–drug interactions in targeted cancer therapies: a focus on tyrosine kinase inhibitors
    Jack C. Stromatt, Anika T. Chowdhury, Kevin M. Huang, Shuiying Hu, Alex Sparreboom, Sharyn D. Baker, Eric D. Eisenmann · 2025 · Expert Review of Clinical Pharmacology
  85. Proanthocyanidin B2 derived metabolites may be ligands for bile acid receptors S1PR2, PXR and CAR: an in silico approach
    Skyler H. Hoang, Kevin M. Tveter, Esther Mezhibovsky, Diana E. Roopchand · 2023 · Journal of Biomolecular Structure and Dynamics
  86. Sclerosing Cholangitis in Baboons ( Papio spp) Resembling Primary Sclerosing Cholangitis of Humans
    Ángela M. Arenas-Gamboa, Jeremy J. Bearss, Gene B. Hubbard, Brian F. Porter, Michael A. Owston, Edward J. Dick · 2011 · Veterinary Pathology
  87. Efflux Transporters
    Paiboon Jungsuwadee, Mary E. Vore · 2010 · Elsevier eBooks
  88. A nose-to-brain axis for spoiled food odor-triggered defensive responses in male mice
    W. Dong, Ping‐Kai Cheng, Jun-Hao Miao, Pei Shi, Ji-Ye Huang, Yu-Xin Jin, Qianqian Lou, Haitao Wang, Zerui Wang, Wan Zhao et al. · 2026 · Nature Communications
  89. Increased PXR and Suppressed T-Cell Signaling Are Associated With Malignant Degeneration of Barrett’s Esophagus
    Sanne Johanna Maria Hoefnagel, Shulin Li, Eva M. Timmer, Sybren Lodewijk Meijer, Kausilia Krishnawatie Krishnadath · 2022 · Gastro Hep Advances
  90. Activation of Alternative Bilirubin Clearance Pathways Partially Reduces Hyperbilirubinemia in a Mouse Model Lacking Functional Ugt1a1 Activity
    Bhaswati Banerjee, Olayemi Joseph Olajide, Giulia Bortolussi, Andrés Fernando Muro · 2022 · International Journal of Molecular Sciences
  91. Metabolic Regulation of Microbiota and Tissue Response
    Zhilu Xu, Manman Chen, Siew C. Ng · 2024 · Gastroenterology Clinics of North America
  92. Pregnane X Receptor in Drug Development
    Su Sien Ong, Yueming Wang, Sergio C. Chai, Taosheng Che · 2011 · InTech eBooks
  93. Bile Acids and Their Receptors
    Thierry Claudel, Michael A Trauner · 2009 · Springer eBooks
  94. Perspective: Five decades of cholestasis research and the brave new world
    Irwin M. Arias · 2008 · Hepatology
  95. Effect of bifendate on the pharmacokinetics of talinolol in healthy subjects
    Yun‐Yun Zeng, F.-Y. He, Yijing He, L.-L. Dai, Lan Fan, H.-H. Zhou · 2009 · Xenobiotica
  96. Crosstalk of 5′-Monophosphate-Activated Protein Kinase (AMPK) with Extracellular and Intracellular Signaling Pathways in the Regulation of Nutrient Metabolism and Cell Survival in the Liver
    Hong Lü · 2017 · Current Pharmacology Reports
  97. Bile Acid-Derived Vitamin D Receptor Ligands
    Makoto Makishima, Sachiko Yamada · 2018 · Elsevier eBooks
  98. Liver and biliary tract disorders
    Richard H. Moseley · 2006 · Current Opinion in Gastroenterology
  99. Nuclear Receptor‐Mediated Regulation of Drug Transporters
    Oliver Burk · 2008
  100. AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity
    Zhen Sun, Bernard Linares, Cassidy Urdiales, Fiyad Al-sarmi, Nagireddy Putluri, Jeanine L. Van Nostrand · 2025 · bioRxiv (Cold Spring Harbor Laboratory)